DIRS.INFO The most relevant business & tech news

☆ What John Blake discovered when he met the White mother he never knew
▼ + stars: | 2023-04-30 | by ( John Blake | ) edition.cnn.com time to read: +25 min

It’s a story about my mother, and the White relatives who shunned me at birth—and still somehow became family. I now know one of the reasons my family didn’t tell me about my mom’s illness is because they didn’t know how. I vividly recall thinking as I looked at my mom: I didn’t know a White person could suffer like this. I saw White, Black, and brown people hug and call each other “brother” and “sister” after worship service. John Blake is a Senior Writer at CNN and the author of “More Than I Imagined: What a Black Man Discovered About the White Mother He Never Knew.”

[1/2] Police officers guard the Tree of Life synagogue following Saturday's shooting at the synagogue in Pittsburgh, Pennsylvania, U.S., October 28, 2018. REUTERS/Aaron JosefczykApril 24 (Reuters) - The man accused of opening fire and killing 11 worshippers in a Pittsburgh synagogue in the deadliest antisemitic attack in U.S. history faces a potential death sentence at the end of a federal trial that begins on Monday with jury selection. Robert Bowers, 50, is accused of dozens of charges, including 11 counts of hate crimes resulting in death, in a massacre that unfolded at Pittsburgh's Tree of Life synagogue on Oct. 27, 2018. In seeking the death penalty, federal prosecutors will try to prove aggravating factors in their case against Bowers, including that he substantially planned the attack and that he targeted vulnerable victims. Federal authorities said Bowers entered the synagogue in the city’s Squirrel Hill neighborhood where many residents are Jewish, armed with multiple firearms.

☆ Fact Check-Posts misidentify Atlanta jail inmate who died after being ‘eaten alive by insects’
▼ + stars: | 2023-04-20 | by ( Reuters Fact Check | ) www.reuters.com time to read: +3 min

A tweet reads, in part, “Lashawn Thompson (below) died after being devoured by insects and brutalized for 3 months in a filthy cell in the Atlanta jail” (archive.ph/X22vW). He died at the Fulton County Jail in Atlanta in September 2022. A search for the photo on the right leads to news reports of a separate incident at an Indiana jail in 2021. The Jackson County Sheriff’s Office didn’t respond to Reuters requests for comment. The posts share photos of inmates who died in separate incidents at jails in Atlanta and Indiana.

☆ Legendary Female Artists on the Younger Women Who Inspire Them
▼ + stars: | 2023-04-20 | by ( ) www.nytimes.com time to read: +20 min

The Artist’s Mind What it feels like for female artists to wrestle with ambition, ego, ambivalence and inheritance. That isolation has, historically, been especially true for women artists, some of the most celebrated of whom have seen “writer” or “painter” or “filmmaker” treated as a secondary part of their identity. For this issue, we asked legendary female artists to tell us about a younger woman whose work excites them and gives them hope. But for the current generation of women artists, who have come of age with models who more closely resemble them, identity seems more like a source of community than a trap. Women artists, born into a Babylon of exclusion and possibility, reveal that creative inheritance is as promiscuous as legal inheritance is strict.

☆ This little-known biotech stock developing treatments for blood disorders could jump 80%, BMO says
▼ + stars: | 2023-03-23 | by ( Sarah Min | ) www.cnbc.com time to read: +2 min

Investors should take a closer look at Disc Medicine as it develops treatments for blood disorders, according to BMO Capital Markets. Analyst Evan David Seigerman initiated coverage of Disc Medicine with an outperform rating and a $40 price target, saying that the firm's development of bitopertin to treat erythropoietic porphyrias and other blood disorders appears promising. IRON YTD mountain Disc Medicine shares YTD Last year, Disc Medicine went public in a reverse merger with biotechnology company Gemini Therapeutics, trading under the ticker symbol "IRON." Disc Medicine shares are up 8% this year. The analyst's $40 price target means that Disc Medicine shares can jump 84% from Wednesday's closing price.

☆ Here are Thursday's biggest analyst calls: Tesla, First Republic, Coinbase, Boeing, Pinterest & more
▼ + stars: | 2023-03-23 | by ( Michael Bloom | ) www.cnbc.com time to read: +7 min

Here are Thursday's biggest calls on Wall Street: Morgan Stanley reiterates Tesla as overweight Morgan Stanley said Tesla could eventually be a solution to vehicle affordability. Truist upgrades BellRing Brands to buy from hold Truist said the time is right to buy shares of the food products company. Citi moves First Republic to an under review rating Citi moved to an under review rating on First Republic due to too much uncertainty. Piper Sandler reiterates Meta and Pinterest as top picks Piper said it's standing by shares of Meta and Pinterest. Oppenheimer downgrades Coinbase to perform from outperform Oppenheimer said it sees an "unhealthy regulatory climate" for Coinbase.

Having a disability in the form of mental illness has shaped my husband's and my financial life in almost every way. We have been fortunate over the years with jobs, health insurance, access to doctors, medications, and the ability to plan for unexpected emergencies like hospitalizations. Our decision to invest in life insurance for my husband is a choice we made based on my disability. Disability affects the big picture aspects of my lifeWe also have to make long-term financial decisions based on my condition. Having a disability makes having and keeping your finances in order simultaneously more important and more difficult.

☆ I made over $10 million in revenue on Amazon last year. Here's how my husband and I became sellers and earned enough to buy our dream home.
▼ + stars: | 2023-03-21 | by ( Julie Peck | ) www.businessinsider.com time to read: +8 min

In 1999, My husband Andy and I became house parents at the Milton Hershey School. The decision for us to eventually go back and become house parents was an easy one. Throughout our 15 years as house parents, we helped raise around 100 junior high- and high school-aged boys while also bringing up our two biological children. While Andy worked for the Amazon business full-time, I stayed at Milton Hershey School and wrote curriculum. Last year, we made more than $10 million in sales, and we have a team of 47 people who we can comfortably pay to run our Amazon business.

☆ U.S. FDA approves Acadia's Rett syndrome drug
▼ + stars: | 2023-03-14 | by ( ) www.reuters.com time to read: +3 min

The approval comes months after the FDA declined to approve expanded use of Acadia's drug Nuplazid to treat psychosis related to Alzheimer's disease. Acadia said it plans to make the drug available to patients by the end of April. He forecast peak U.S. trofinetide sales of $487.2 million by 2035. After the FDA declined to approve the expanded use of Nuplazid, Acadia said it would not pursue that indication for Nuplazid further. Improvement of symptoms was measured according to the assessment scales Rett Syndrome Behaviour Questionnaire and the Clinical Global Impression of Improvement.

☆ ‘I Live in Hell’: The Psychic Wounds of Ukraine’s Soldiers
▼ + stars: | 2023-03-14 | by ( Photographs Antoine D Agata | Text Ellen Barry | ) www.nytimes.com time to read: +15 min

The soldier’s ward is a quiet place, high-ceilinged, with chess boards and a Ping-Pong table; you could mistake it for a rest home, except that the door handles have been removed. Tap Click to read their stories Oleksandr, 21 Occupation: Soldier, former student “I finished school and joined the army in 2021. Now I’m mostly sad; I’m better off alone.” Yulia, 47 Occupation: Soldier; combat medic, independent forensic expert I’m a combat medic. Stanislav, 29 Occupation: Soldier, former cook “I didn’t plan to end up here. I adjust to each person in this way.” Serhii, 42 Occupation: Soldier, former employee at a shipping company On April 28 2022, I joined the air assault forces.

☆ U.S. FDA approves Acadia's genetic Rett syndrome drug
▼ + stars: | 2023-03-11 | by ( ) www.reuters.com time to read: +3 min

March 10 (Reuters) - The U.S. Food and Drug Administration approved Acadia Pharmaceuticals Inc's (ACAD.O) drug for the treatment of Rett syndrome, a genetic brain disorder, the company said on Friday, making it the first approved drug for the condition. The approval comes months after the FDA declined to approve expanded use of Acadia's drug Nuplazid to treat psychosis related to Alzheimer's disease. Acadia said it plans to make the drug available to patients by the end of April. He forecast peak U.S. trofinetide sales of $487.2 million by 2035. Improvement of symptoms was measured according to the assessment scales Rett Syndrome Behaviour Questionnaire and the Clinical Global Impression of Improvement.

☆ Are left handed people more creative? Brain scans reveal why these individuals might be wired differently
▼ + stars: | 2023-03-07 | by ( Erin Heger | ) www.businessinsider.com time to read: +7 min

In particular, they display less brain lateralization than right-handers, said Eric Zillmer, a professor of neuropsychology at Drexel University. Because lefties rely less on the left hemisphere, researchers describe this as displaying less brain lateralization, Zillmer said. Zillmer said these differences in brain lateralization may help left-handers think more outside the box and therefore have a more creative edge. "Our creative brain is utilized when we are engaging in new, unfamiliar experiences," Bajaj said. If you want to use your left hand more often, practice.

☆ U.S. regulators rejected Elon Musk’s bid to test brain chips in humans
▼ + stars: | 2023-03-02 | by ( ) www.reuters.com time to read: +23 min

Musk’s missed deadlines for FDA approval of Neuralink July 2019:Musk says Neuralink is aiming to receive regulatory approval for human trials of brain implants by the end of 2020. “Everybody in the industry was saying: ‘Oh my God, they’re going to run straight into a brick wall,’” Ludwig said of Musk’s bid for FDA approval. For example, NeuroPace, which makes the brain implant to treat epilepsy, received final FDA approval in 2013 – 16 years after the company’s launch. The FDA’s concerns about the battery are also potentially serious, experts in brain devices said. Still, that proposal disappointed Neuralink because it could delay progress toward final FDA approval, one of the sources said.

☆ U.S. regulators rejected Elon Musk’s bid to test brain chips in humans, citing safety risks
▼ + stars: | 2023-03-02 | by ( Rachael Levy | Marisa Taylor | ) www.cnbc.com time to read: +19 min

Companies that do secure human-testing approval typically conduct at least two rounds of trials before applying for FDA approval to commercially market a device. "Everybody in the industry was saying: 'Oh my God, they're going to run straight into a brick wall,'" Ludwig said of Musk's bid for FDA approval. For example, NeuroPace, which makes the brain implant to treat epilepsy, received final FDA approval in 2013 – 16 years after the company's launch. Beyond grants, it provides access to government experts who advise on how to gain FDA approval and commercialize a device. Musk's emails to Neuralink staffers often come from his SpaceX address, said two people who reviewed them.

Prosecutors presented sufficient evidence to proceed with their case against Anderson Lee Aldrich on all charges filed in the Nov. 19 shooting rampage at Club Q club in Colorado Springs, the El Paso County district judge ruled. Besides multiple counts of first-degree murder, Aldrich faces dozens of counts of attempted murder and assault, as well as hate-crimes charges alleging the attack was motivated by prejudice against victims' sexual or gender identities. Thursday's ruling capped a two-day preliminary hearing in which prosecutors outlined their case for trying Aldrich on all charges. A hand-sketched map of Club Q was also found in a search of the defendant's home, Gasper said. Two patrons with military training subdued Aldrich and held the suspect until police arrived, according to the arrest warrant affidavit.

☆ Biotech stocks that could surge more than 35% include one name targeting treatments for schizophrenia
▼ + stars: | 2023-02-09 | by ( Sarah Min | ) www.cnbc.com time to read: +3 min

Still, the outlook for biotech stocks could improve now , with innovation in new drugs and more merger and acquisition activity driving investor interest. Recently, Wall Street has been zoning in on developments in treatments for Alzheimer's diseases, drugs for weight loss and treatments using gene editing. CNBC Pro screened for biotech stocks that are part of the iShares Biotechnology ETF , searching for names with huge upside from current prices. In January, Piper Sandler initiated research coverage of Karuna with an overweight rating, saying it's "blazing a new trail in Schizophrenia" treatments. The stock was named another top 2023 pick by Piper Sandler, which said Legend has a "best-in-class" treatment for adults with relapsed multiple myeloma, a segment "with demand far outpacing supply."

☆ Analysts love these AI stocks with big upside potential to play the ChatGPT-driven artificial intelligence craze
▼ + stars: | 2023-02-07 | by ( Tanaya Macheel | ) www.cnbc.com time to read: +2 min

Each name in the list that follows has potential upside of about 35% or more, buy ratings from at least 60% of analysts and at least 10 analysts covering the stock. It has about 39% potential upside and buy ratings from almost 62% of the analysts covering it. Intellia Therapeutics , a company focused on gene-editing treatments, has upside potential of about 140% and buy ratings from 72% of its 27 analysts. Denali Therapeutics , which is focused on defeating neurodegenerative diseases, is close behind, with upside potential of 104% and buy ratings from almost 89% of its 18 analysts. Karuna Therapeutics , which specializes in schizophrenia treatments, holds the largest percentage of buy ratings, coming from 95% of its 20 analysts.

☆ Colorado supermarket shooting suspect remains unfit for trial, judge says
▼ + stars: | 2023-01-29 | by ( The Associated Press | ) www.nbcnews.com time to read: +3 min

BOULDER, Colo. — A man charged with killing 10 people at a Colorado supermarket nearly two years ago remains mentally incompetent to stand trial, a judge said Friday. Bakke said the latest report from the hospital finding Alissa incompetent also said he has a “reasonable likelihood” of reaching competency, an outlook also expressed in previous reports. Concerns about Alissa’s mental health were raised by his defense immediately after the March 2021 shooting. Competency is a different legal issue than a plea of not guilty by reason of insanity, which involves whether someone’s mental health prevented them from understanding right from wrong when a crime was committed. They said Alissa passed a background check to legally buy a Ruger AR-556 pistol six days before the shooting.

☆ A woman with severe mental illness lay dead in her apartment for more than 3 years before being found, say reports
▼ + stars: | 2023-01-28 | by ( Alia Shoaib | ) www.businessinsider.com time to read: +3 min

Laura Winham, 38, lay dead for more than three years in Surrey, England, before being found. Her family alleges that she was "abandoned and left to die" by national health and social services. Laura Winham, 38, was found in May 2021 when her family tried to enter her home to inform her of her father's passing. "No one should have to suffer the way Laura did due to the lack of support given to her mental health. Social services attempted to call her, despite police telling them her phone was not working and sent her information about local services in the mail before closing the case without making a welfare check.

☆ Mass Shootings in the U.S.: A Symptom of Despair - The New York Times
▼ + stars: | 2023-01-26 | by ( Jillian Peterson | James Densley | ) www.nytimes.com time to read: +23 min

Seven killed and 46 injured in Highland Park, Ill., on July 4, 2022He suffered from severe back pain. Eight killed and seven injured in Indianapolis on April 15, 2021He was known for being paranoid with a short temper. Five killed and seven injured in Aurora, Ill., on Feb. 15, 2019He had expressed violent thoughts. Nine killed and seven injured in Red Lake, Minn., on March 21, 2005He had been noticeably depressed and angry at church. Seven killed and seven injured in Fort Worth on Sept. 15, 1999He killed his daughter’s cat because he was upset.

☆ '9-1-1: Lone Star' actors preview the journey 'Tarlos' must take to the wedding altar
▼ + stars: | 2023-01-25 | by ( Max Gao | Max Gao Is A Freelance Entertainment | Sports Journalist Based In Toronto. He Has Written For Nbc News | ) www.nbcnews.com time to read: +8 min

This article contains spoilers for “The New Hotness,” Tuesday’s season premiere of “9-1-1: Lone Star.”After getting engaged to police officer Carlos Reyes (Rafael L. Silva), paramedic T.K. Strand (Ronen Rubinstein) was hit with a shocking secret in the season four premiere of “9-1-1: Lone Star”: Carlos was already legally married to a woman. are on their path to becoming a legally unified couple.”From left, Ronen Rubinstein, Rafael L. Silva, and Lyndsy Fonseca in '9-1-1: Lone Star'. and Carlos in recent months has centered around their impending nuptials, Silva cautioned that their journey to the wedding altar will be anything but straightforward. “There’s a lot of 'Tarlos' in the first half of the season.”“9-1-1: Lone Star” airs Tuesdays at 8 p.m. ET/PT on Fox.

☆ People with insomnia and sleep paralysis are more likely to believe in aliens, the afterlife, and 'things that go bump in the night,' researchers find
▼ + stars: | 2023-01-21 | by ( Katherine Tangalakis-Lippert | ) www.businessinsider.com time to read: +5 min

A study in the Journal of Sleep Research found poor sleep correlates with paranormal beliefs. People with insomnia and sleep paralysis more often believe in ghosts, aliens, and an afterlife. The study's authors told Insider the results could improve health care, but there's more to learn. Those who see them may have one thing in common, according to a new study published in the Journal of Sleep Research: sleep disturbances. Sleep paralysis was also highly associated with the belief that near-death experiences are evidence of life after death.

☆ Nursing Homes’ Use of Schizophrenia Drugs to Be Audited by U.S. Government
▼ + stars: | 2023-01-19 | by ( Liz Essley Whyte | ) www.wsj.com time to read: 1 min

The Centers for Medicare and Medicaid Services said it would factor in use of antipsychotic medicines in nursing-home ratings. Federal health officials said they would take steps to increase oversight of nursing homes that prescribe powerful antipsychotic drugs, and prevent abuse of the medicines. The Centers for Medicare and Medicaid Services said Wednesday it would begin auditing nursing homes to see if they are accurately diagnosing their residents as schizophrenic, and would factor in use of antipsychotic medicines in nursing-home ratings.

☆ Investors piled a record $12.6 billion into wellness apps during the pandemic. Now they're starting to bet on startups tackling mental illnesses.
▼ + stars: | 2023-01-13 | by ( Riddhi Kanetkar | ) www.businessinsider.com time to read: +5 min

The COVID-19 pandemic created a wellness boom across Europe, with mindfulness apps growing rapidly. VCs pumped a record $771 million into European startups tackling mental illnesses in 2021, per Dealroom. But psychologists have been clear that they are not substitutes for clinically-approved treatments for mental health conditions. Now, there is a new wave of startups looking to move beyond wellness and tackle mental illnesses. "The scale of the problem of mental illnesses became evident after COVID-19," Joseph Zipfel, chief investment officer at SFC, told Insider.

☆ The CEO of a psychedelics giant that just suffered a big setback lays out why investors should bet on his long-term vision
▼ + stars: | 2023-01-11 | by ( Yeji Jesse Lee | ) www.businessinsider.com time to read: +4 min

PCN-101, a ketamine-based treatment, failed to help people with treatment-resistant depression. CEO Florian Brand said he thinks investors should bet on the company's long-term vision. Florian Brand, the CEO of the psychedelics giant Atai Life Sciences, said investors should look past the company's recent failed clinical trial and bet on his long-term vision for the company. On January 6, Atai announced that a highly anticipated trial of a ketamine-based depression treatment failed to meet its goals. The company also owns a large stake in the psychedelics company Compass Pathways, which is currently in late-stage trials to develop psilocybin, the psychoactive ingredient found in magic mushrooms, for treatment-resistant depression.

Search resuls for: "Schizophrenia"

25 mentions found